Simple blood test may predict people at highest risk for developing heart...
For years, doctors have been divided on how effective annual testing and screenings are for apparently healthy individuals. New research, however, shows that a simple blood test may predict who is at...
View ArticleFDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection
Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration has approved OLYSIO (simeprevir), an NS3/4A protease inhibitor, for the treatment of...
View ArticleHigh-potency statins offer improved chance of survival in heart attack patients
A study looking at the data of thousands of patients who suffered heart attacks has suggested treatment with high-potency statins offers a significantly improved chance of survival compared to those...
View ArticleChina Pharma Holdings' revenue decreases 40% to $32.8 million in fiscal year...
China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the year ended December...
View ArticleJanssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for...
Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A...
View ArticleRosuvastatin promotes bone growth in mice with achondroplasia symptoms
Skeletal dysplasia is a group of rare diseases that afflict skeletal growth through abnormalities in bone and cartilage. Its onset hits at the fetal stage and is caused by genetic mutations.
View ArticleRosuvastatin drug more effective among prediabetic patients, finds new study
Cardiovascular disease is the leading causes of death worldwide and high cholesterol plays a major role in accelerating its progression. Medical practitioners have turned to statins as a treatment to...
View ArticleAustralian Prescriber publishes top 10 subsidised drugs in Australia
The annual publication of the top 10 subsidised drugs appears in the December edition of Australian Prescriber. Statins (cholesterol-lowering medicines) top the lists again.
View ArticleJanssen, Gilead to jointly develop darunavir-based, single-tablet regimen for...
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based,...
View ArticleChina Pharma's revenue decreases 24% to $24.9 million in fiscal year 2014
China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the year ended December...
View ArticleFirst generic version of Crestor gets FDA approval
The U.S. Food and Drug Administration today approved the first generic version of Crestor (rosuvastatin calcium) tablets.
View ArticleStudy shows short-term statin treatment does not benefit heart surgery patients
Giving daily doses of statins for a few days before and after heart surgery does not prevent heart muscle damage or the development of atrial fibrillation (AF), according to an international clinical...
View ArticleNew report reveals prescription medication costs may increase up to 13% in 2016
Prescription medication costs are expected to rise at least 11 percent, and possibly up to 13 percent, in 2016, according to a new report on national trends and projections in prescription drug...
View ArticleHigh-intensity statin treatments increase survival rates in patients with...
A large national study has confirmed the value of high-intensity statin treatments for people with cardiovascular disease, according to researchers at the Stanford University School of Medicine.
View ArticleCommon anti-cholesterol drugs show promise for reducing Alzheimer's disease risk
Common anti-cholesterol drugs show promise for reducing the risk of Alzheimer's disease, a University of Southern California-led study of Medicare data reveals.
View ArticleRosuvastatin promotes bone growth in mice with achondroplasia symptoms
Skeletal dysplasia is a group of rare diseases that afflict skeletal growth through abnormalities in bone and cartilage. Its onset hits at the fetal stage and is caused by genetic mutations.
View ArticleRosuvastatin drug more effective among prediabetic patients, finds new study
Cardiovascular disease is the leading causes of death worldwide and high cholesterol plays a major role in accelerating its progression. Medical practitioners have turned to statins as a treatment to...
View ArticleAustralian Prescriber publishes top 10 subsidised drugs in Australia
The annual publication of the top 10 subsidised drugs appears in the December edition of Australian Prescriber. Statins (cholesterol-lowering medicines) top the lists again.
View ArticleJanssen, Gilead to jointly develop darunavir-based, single-tablet regimen for...
Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based,...
View ArticleChina Pharma's revenue decreases 24% to $24.9 million in fiscal year 2014
China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the year ended December...
View Article
